Prometheus Biosciences Probability of Future Stock Price Finishing Under 124.31
| RXDXDelisted Stock | USD 199.92 0.24 0.12% |
Prometheus |
Prometheus Biosciences Target Price Odds to finish below 124.31
The tendency of Prometheus Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 124.31 or more in 90 days |
| 199.92 | 90 days | 124.31 | about 14.85 |
Based on a normal probability distribution, the odds of Prometheus Biosciences to drop to $ 124.31 or more in 90 days from now is about 14.85 (This Prometheus Biosciences probability density function shows the probability of Prometheus Stock to fall within a particular range of prices over 90 days) . Probability of Prometheus Biosciences price to stay between $ 124.31 and its current price of $199.92 at the end of the 90-day period is about 64.62 .
Given the investment horizon of 90 days Prometheus Biosciences has a beta of -0.0684 indicating as returns on the benchmark increase, returns on holding Prometheus Biosciences are expected to decrease at a much lower rate. During a bear market, however, Prometheus Biosciences is likely to outperform the market. Moreover Prometheus Biosciences has an alpha of 1.0308, implying that it can generate a 1.03 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Prometheus Biosciences Price Density |
| Price |
Predictive Modules for Prometheus Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Prometheus Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Prometheus Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Prometheus Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Prometheus Biosciences is not an exception. The market had few large corrections towards the Prometheus Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Prometheus Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Prometheus Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.03 | |
β | Beta against Dow Jones | -0.07 | |
σ | Overall volatility | 40.53 | |
Ir | Information ratio | 0.12 |
Prometheus Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Prometheus Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Prometheus Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Prometheus Biosciences is not yet fully synchronised with the market data | |
| Prometheus Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 6.81 M. Net Loss for the year was (141.75 M) with loss before overhead, payroll, taxes, and interest of (106.04 M). | |
| Prometheus Biosciences currently holds about 95.96 M in cash with (123.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.35. | |
| Over 81.0% of the company shares are owned by institutional investors |
Prometheus Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Prometheus Stock often depends not only on the future outlook of the current and potential Prometheus Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Prometheus Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 40.6 M | |
| Cash And Short Term Investments | 695.8 M |
Prometheus Biosciences Technical Analysis
Prometheus Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Prometheus Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Prometheus Biosciences. In general, you should focus on analyzing Prometheus Stock price patterns and their correlations with different microeconomic environments and drivers.
Prometheus Biosciences Predictive Forecast Models
Prometheus Biosciences' time-series forecasting models is one of many Prometheus Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Prometheus Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Prometheus Biosciences
Checking the ongoing alerts about Prometheus Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Prometheus Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Prometheus Biosciences is not yet fully synchronised with the market data | |
| Prometheus Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 6.81 M. Net Loss for the year was (141.75 M) with loss before overhead, payroll, taxes, and interest of (106.04 M). | |
| Prometheus Biosciences currently holds about 95.96 M in cash with (123.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.35. | |
| Over 81.0% of the company shares are owned by institutional investors |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Prometheus Stock
If you are still planning to invest in Prometheus Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Prometheus Biosciences' history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |